L'entreprise vient de rembourser à l'Etat un crédit d'impôt qu'elle avait perçu pour l'une de ses usines... Et relance le ...

An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly improved recurrence risk stratification in hormone receptor (HR)-positive, ...

Looking back on specialized technology stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including PAR Technology (NYSE:PAR) and its peers. Companies in this sector, especially ...

Restaurant technology provider PAR Technology (NYSE:PAR) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 23.2% year on year to $119.2 million. Its non-GAAP profit of $0 ...

PAR Technology Corporation has been a stock in the portfolio since the Fund’s inception. PAR reported a Q2 2025 earnings result that disappointed investors, sending the stock down by 19% in the ...

Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...

A common over-the-counter medication could significantly reduce the risk of colorectal cancer coming back. In a Swedish study, a low dose of aspirin was shown to slash recurrence in half for patients ...

PAR AI delivers real-time intelligence that flows seamlessly across the restaurant tech stack without the need for extra apps or training Unlike AI add-ons that create complexity and enable silos, PAR ...

NEW HARTFORD, N.Y.--(BUSINESS WIRE)--PAR Technology Corporation (NYSE: PAR), a leading foodservice technology provider, today announced the launch of PAR ® AI, the new intelligence layer embedded ...

Unlike AI add-ons that create complexity and enable silos, PAR AI-powered features are built into the core of PAR's products—spanning POS, back office, loyalty, drive-thru, and payments—with no ...